Mark received his J.D. magna cum laude, from Benjamin N. Cardozo School of Law, where he was a Dean’s Distinguished Scholar, and served as Associate Editor of the Cardozo Law Review. In law school, Mark served as a full-time judicial intern to the Honorable Colleen McMahon of the United States District Court for the Southern District of New York. He received his B.S., cum laude, in Applied Economics and Management from Cornell University. Mark has an active pro bono practice, including representing and counseling pro bono clients in housing rights cases. Mark is also a contributor to the Weil Restructuring Blog.
Mark has been a member of teams representing various parties in a number of in-court and out-of-court restructurings, including:
- Core Scientific, one of the world’s largest cryptocurrency mining and hosting companies with approximately $1 billion in debt in evaluating strategic options in light of falling Bitcoin prices and other headwinds in cryptocurrency industry
- Johnson & Johnson as a creditor in the mass tort chapter 11 cases of Imerys Talc America, Inc., which filed for chapter 11 as a result of tens of thousands of personal injury lawsuits
- National Public Finance Guarantee Corporation, in connection with the Title III cases of the Commonwealth of Puerto Rico and certain of its instrumentalities.
In Vacating Purdue Pharma’s Confirmation Order, the District Court Determines that the Plan’s Nonconsensual Third-Party Releases Are Not Statutorily Authorized
Blog Post — Weil Restructuring
— December 30, 2021
We’ve written extensively here, here, and here on the issue of third-party releases in chapter 11 plans. Widespread interest in third-party releases appeared to reach peak status in 2021 with the high-profile nature and broad impact of several recent chapter 11 cases of multi-billion dollar companies, including those wrestling with opioid fallout like Purdue Pharma. ...